Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
No matter how you cast your ballot in the presidential election last month, recent history suggests your vote counts for IPOs.
The offer would put an 83% premium on Soho’s Wednesday closing price and comes a year after it had to close off admissions in three cities.
One ring to rule them all… at least, Oura hopes so. On Thursday, it announced a new $200 million funding round.